CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,081 Cr | ₹951 Cr | ₹754 Cr | ₹536 Cr | ₹288 Cr |
What is the latest Net Current Assets ratio of CONCORD BIOTECH ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,081 Cr |
| Mar2025 | ₹951 Cr |
| Mar2024 | ₹754 Cr |
| Mar2023 | ₹536 Cr |
| Mar2022 | ₹288 Cr |
How is Net Current Assets of CONCORD BIOTECH Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,081 Cr | 13.65 | |
| Mar2025 | ₹951 Cr | 26.14 | |
| Mar2024 | ₹754 Cr | 40.72 | |
| Mar2023 | ₹536 Cr | 85.79 | |
| Mar2022 | ₹288 Cr | - | |
Compare Net Current Assets of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹15,126.2 Cr | 2.1% | 7.6% | -11% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 2.1% |
7.6% |
-11% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses